On an emergency basis, a vaccine against the coronavirus could be ready in autumn, provided it proves safe in tests. A first step was taken by Bio N Tech and Pfizer: the companies announced completion of dosing for a first cohort of Phase 1/2 trial of Covid-19 vaccine candidates in Germany.
Read on